bismuth has been researched along with sorafenib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, Y; Dong, L; Li, Y; Liu, J; Liu, TT; Shen, XZ; Sun, Y; Weng, SQ; Yu, XN; Zhang, GC; Zhu, CF; Zhu, JM | 1 |
| Rahimi, HR; Ranjbar, M; Samarehfekri, H | 1 |
2 other study(ies) available for bismuth and sorafenib
| Article | Year |
|---|---|
Bismuth-Based Mesoporous Nanoball Carrying Sorafenib for Computed Tomography Imaging and Synergetic Chemoradiotherapy of Hepatocellular Carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bismuth; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Chemoradiotherapy; Liver Neoplasms; Mice; Niacinamide; Sorafenib | 2020 |
Controlled and cellulose eco-friendly synthesis and characterization of Bi
Topics: Antineoplastic Agents; Bismuth; Carbonates; Cellulose; Drug Delivery Systems; Green Chemistry Technology; Juglans; Quantum Dots; Sorafenib | 2020 |